1. Home
  2. PULM vs APYX Comparison

PULM vs APYX Comparison

Compare PULM & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • APYX
  • Stock Information
  • Founded
  • PULM 2003
  • APYX 1982
  • Country
  • PULM United States
  • APYX United States
  • Employees
  • PULM N/A
  • APYX N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • APYX Medical/Dental Instruments
  • Sector
  • PULM Health Care
  • APYX Health Care
  • Exchange
  • PULM Nasdaq
  • APYX Nasdaq
  • Market Cap
  • PULM 30.9M
  • APYX 36.8M
  • IPO Year
  • PULM N/A
  • APYX 1987
  • Fundamental
  • Price
  • PULM $6.20
  • APYX $1.16
  • Analyst Decision
  • PULM
  • APYX Hold
  • Analyst Count
  • PULM 0
  • APYX 2
  • Target Price
  • PULM N/A
  • APYX N/A
  • AVG Volume (30 Days)
  • PULM 8.4K
  • APYX 54.9K
  • Earning Date
  • PULM 05-20-2025
  • APYX 05-08-2025
  • Dividend Yield
  • PULM N/A
  • APYX N/A
  • EPS Growth
  • PULM N/A
  • APYX N/A
  • EPS
  • PULM N/A
  • APYX N/A
  • Revenue
  • PULM $7,806,000.00
  • APYX $47,288,000.00
  • Revenue This Year
  • PULM N/A
  • APYX $1.85
  • Revenue Next Year
  • PULM $134.88
  • APYX $7.72
  • P/E Ratio
  • PULM N/A
  • APYX N/A
  • Revenue Growth
  • PULM 6.96
  • APYX N/A
  • 52 Week Low
  • PULM $1.72
  • APYX $0.76
  • 52 Week High
  • PULM $10.40
  • APYX $1.99
  • Technical
  • Relative Strength Index (RSI)
  • PULM 46.38
  • APYX 54.22
  • Support Level
  • PULM $5.88
  • APYX $1.04
  • Resistance Level
  • PULM $6.85
  • APYX $1.31
  • Average True Range (ATR)
  • PULM 0.30
  • APYX 0.13
  • MACD
  • PULM 0.02
  • APYX 0.03
  • Stochastic Oscillator
  • PULM 30.93
  • APYX 69.07

About PULM Pulmatrix Inc.

Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Share on Social Networks: